Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections

References

• European centre for disease prevention and control. Antimicrobial resistance surveillance in Europe 2015. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antimicrobial-resistance-europe-2015.pdf
   Google Scholar
• European centre for disease prevention and control. Antimicrobial resistance surveillance in Europe 2012. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available from: https://ecdc.europa.eu/en/publications/publications/antimicrobial-resistance-surveillance-europe-2012.pdf
   Google Scholar
• European centre for disease prevention and control. Point Prevalence Survey of Healthcare-associated infections and antimicrobial use in European long-term care facilities. 2013 April–May. Available from: https://ecdc.europa.eu/en/publications/publications/healthcare-associated-infections-point-prevalence-survey-long-term-care-facilities-2013.pdf.
   Google Scholar
• L’uso dei farmaci in Italia, Rapporto Nazionale Anno 2015. Available from: www.agenziafarmaco.gov.it.
   Google Scholar
• Komp Lindgren P, Klockars O, Malmberg C, Cars O. Pharmacodynamic studies of nitrofurantoin against common uropathogens. J Antimicrob Chemother. 2015;70(4):1076–82.
   PubMed Web of Science ®Google Scholar
• Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. JAntimicrob Chemother. 2015;70:2456–64.10.1093/jac/dkv147
   PubMed Web of Science ®Google Scholar
• Price JR, Guran LA, Gregory WT, McDonagh MS. Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2016;215(5):548–60.10.1016/j.ajog.2016.07.040
   PubMed Web of Science ®Google Scholar
• Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonehritis in women: A 2010 update by the IDSA and European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–20.10.1093/cid/ciq257
   PubMed Web of Science ®Google Scholar
• European Association of Urology (EAU). Guidelines on urological infections; 2017. Available from: http://uroweb.org/guideline/urological-infections/.
   Google Scholar
• Dewar S, Reed LC, Koerner RJ. Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria. J Antimicrob Chemother. 2014;69:303–8.
   Google Scholar
• Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents. 2009;34(2):111–20.10.1016/j.ijantimicag.2009.03.009
   PubMed Web of Science ®Google Scholar
• Stein GE. Fosfomycin tromethamine: single-dose treatment of acute cystitis. Int J Fertil Womens Med. 1999;44:104–9.
   PubMedGoogle Scholar
• Pullukcu H, Tasbakan M, Sipahi O, Yamazhan T, Aydemir S, Ulusoy S. Fosfomycin in the treatment of extended spectrum beta-lactamase producing Escherichia coli-related lower urinary tract infections. Int J Antimicrob Agents. 2007;29:62–5.10.1016/j.ijantimicag.2006.08.039
   PubMed Web of Science ®Google Scholar
• Senol T, Tasbakan M, Pullukcu H, Sipahi OR, Sipahi H, Yamazhan T, et al. Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection. J Chemother. 2010;22:355–7.10.1179/joc.2010.22.5.355
   PubMed Web of Science ®Google Scholar
• Ho JM, Juurlink DN. Considerations when prescribing trimethoprim-sulfamethoxazole. Can Med Assoc J. 2011;183(16):1851–8.10.1503/cmaj.111152
   PubMed Web of Science ®Google Scholar
• Caron F. Diagnostic et antibiothèrapie des infections urinaires bactèriennes communautaires de l’adult. SPLIF. 2014. Available from: https://www.infectiologie.com/UserFiles/File/spilf/recos/infections-urinaires-spilf.pdf.
   Google Scholar
• Battaglia M, Cai T, Concia E, De Nunzio C, Mazzei T, Pea F, et al. Raccomandazioni in tema di diagnosi, trattamento e profilassi delle infezioni delle vie urinarie, versione 1 anno 2015 SIU-UTI. Available from: https://www.siu.it/files/uploads/Linee_Guida_SIU_UTI_2015.pdf.
   Google Scholar
• Urinary tract infections in women BMJ Best Practice 2015. Available from: https://bestpractice.bmj.com/best-practice/monograph/77/treatment/step-by-step.html.
   Google Scholar
• Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, et al. Epidemiology, diagnostic, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients: Update 2017 of the interdisciplinary AWMF S3 guideline. Urologie A. 2017;56(6):746–58.10.1007/s00120-017-0389-1
   PubMed Web of Science ®Google Scholar
• Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents. 2000;16(1):5–15.10.1016/S0924-8579(00)00192-8
   PubMed Web of Science ®Google Scholar
• Peterson LR. Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity. Clin Infect Dis. 2001;33(Suppl 3):S180–6.10.1086/cid.2001.33.issue-s3
   PubMedGoogle Scholar
• Chen YH, Ko WC, Hsueh PR. The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens. Eur J Clin Microbiol Infect Dis. 2012;31(8):1699–704.10.1007/s10096-011-1457-x
   PubMed Web of Science ®Google Scholar
• FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. Media release. 2016 Jul 26. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm511530.htm.
   Google Scholar
• Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643–54.10.1086/427507
   PubMed Web of Science ®Google Scholar
• Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev. 2012;11:CD009279.
   PubMedGoogle Scholar
• Preventive US. Services task force. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008;149(1):43–47.
   PubMed Web of Science ®Google Scholar
• Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335(7):468–74.10.1056/NEJM199608153350703
   PubMed Web of Science ®Google Scholar
• Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis. 1999;29(1):113–9.10.1086/524645
   PubMed Web of Science ®Google Scholar
• Grigoryan L, Zoorob R, Wang H, Trautner BW. Low concordance with guidelines for treatment of acute cystitis in primary care. Open Forum Infect Dis. 2015;2(4):1–6.
   Google Scholar
• Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80(3):331–3.10.2105/AJPH.80.3.331
   PubMed Web of Science ®Google Scholar
• Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28(1):68–75.10.1016/S0196-6553(00)90015-4
   PubMed Web of Science ®Google Scholar
• Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14.10.1086/668770
   PubMed Web of Science ®Google Scholar
• Krieger JN, Ross SO, Simonsen JM. Urinary tract infections in healthy university Men. J Urol. 1993;149(5):1046–8.10.1016/S0022-5347(17)36292-4
   PubMed Web of Science ®Google Scholar
• Abarbanel J, Engelstein D, Lask D, Livne PM. Urinary tract infection in men younger than 45 years of age: is there a need for urologic investigation? Urology. 2003;62(1):27–9.10.1016/S0090-4295(03)00146-8
   PubMed Web of Science ®Google Scholar
• Gardiner BJ, Mahony AA, Ellis AG, Lawrentschuk N, Bolton DM, Zeglinski PT, et al. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis. 2014;58(4):e101–5.10.1093/cid/cit704
   PubMed Web of Science ®Google Scholar
• Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N Eng J Med. 1993;329(11):753–6.10.1056/NEJM199309093291102
   PubMed Web of Science ®Google Scholar
• Di Silverio F, Ferrone G, Carati L. Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manoeuvres. Results of a multicentre study. Infection. 1990;18(Suppl 2):S98–102.
   PubMedGoogle Scholar
• Sen V, Aydogdu O, Bozkurt IH, Yonguc T, Sen P, Polat S, et al. The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study. Can Urol Assoc J. 2015;9(11–12):863–7.10.5489/cuaj.3068
   Web of Science ®Google Scholar
• Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, et al. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol. 2017;35:221–8.10.1007/s00345-016-1867-6
   PubMed Web of Science ®Google Scholar